Filing Details

Accession Number:
0001654954-23-009402
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-07-19 16:03:32
Reporting Period:
2023-07-17
Accepted Time:
2023-07-19 16:03:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1040470 Aehr Test Systems AEHR Instruments For Meas & Testing Of Electricity & Elec Signals (3825) 942424084
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1652627 B. Kenneth Spink C/O Aehr Test Systems
400 Kato Terrace
Fremont CA 94539
Vp Of Finance And Cfo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-07-17 11,511 $2.40 11,511 No 4 M Direct
Common Stock Acquisiton 2023-07-17 25,000 $1.64 36,511 No 4 M Direct
Common Stock Disposition 2023-07-17 36,511 $51.39 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2023-07-17 25,000 $0.00 25,000 $1.64
Common Stock Incentive Stock Option (right to buy) Disposition 2023-07-17 11,511 $0.00 11,511 $2.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-08-16 2026-07-16 No 4 M Direct
0 2018-09-17 2025-08-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 109,866 Indirect by Trust
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.25 to $51.75, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
  2. The amount reported includes shares subject to unvested restricted stock units.
  3. One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.